KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Repligen (RGEN) Non Operating Income (2016 - 2025)

Repligen (RGEN) has disclosed Non Operating Income for 15 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 131.28% to $4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Dec 2025, up 199.11% year-over-year, with the annual reading at $7.2 million for FY2025, 239.47% up from the prior year.
  • Non Operating Income for Q4 2025 was $4.8 million at Repligen, up from -$804000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $6.7 million in Q3 2023, with the low at -$15.9 million in Q4 2023.
  • Average Non Operating Income over 5 years is -$640700.0, with a median of -$135000.0 recorded in 2024.
  • The sharpest move saw Non Operating Income plummeted 1497.58% in 2021, then skyrocketed 2581.82% in 2025.
  • Over 5 years, Non Operating Income stood at $621000.0 in 2021, then surged by 568.12% to $4.1 million in 2022, then crashed by 484.04% to -$15.9 million in 2023, then rose by 3.6% to -$15.4 million in 2024, then soared by 131.28% to $4.8 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $4.8 million, -$804000.0, and $3.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.